Transcranial Direct Current Stimulation Over Dorsolateral Prefrontal Cortex in Alcoholism
|First Received Date ICMJE||April 5, 2011|
|Last Updated Date||September 24, 2013|
|Start Date ICMJE||June 2011|
|Primary Completion Date||July 2013 (final data collection date for primary outcome measure)|
|Current Primary Outcome Measures ICMJE
||Use of Alcohol [ Time Frame: 6 months after treatment ] [ Designated as safety issue: No ]
relapse to the use of alcohol to a usual pattern observed before treatment
|Original Primary Outcome Measures ICMJE
||use of alcohol [ Time Frame: one year and a half ] [ Designated as safety issue: No ]|
|Change History||Complete list of historical versions of study NCT01330394 on ClinicalTrials.gov Archive Site|
|Current Secondary Outcome Measures ICMJE
|Original Secondary Outcome Measures ICMJE||Same as current|
|Current Other Outcome Measures ICMJE||Not Provided|
|Original Other Outcome Measures ICMJE||Not Provided|
|Brief Title ICMJE||Transcranial Direct Current Stimulation Over Dorsolateral Prefrontal Cortex in Alcoholism|
|Official Title ICMJE||Alcoholism Treatment by Cognitive Neuromodulation Produced by Repeated Transcranial Direct Current Stimulation Over the Left Dorsolateral Prefrontal Cortex|
Alcohol dependency is the most frequent addiction leading to a massive burden of both, patients health, and economy. Present therapeutic concepts suffer from limited efficacy, and thus new innovative therapies are needed. Neuroscientific studies have shown that prefrontal function in alcohol-dependent patients is impaired, leading to cognitive disturbances, and continuation of dependent behaviour. The results of pilot studies demonstrate that activation of prefrontal cortices via non-invasive brain stimulation improves cognitive performance in healthy subjects, and diminishes dependency-related behaviour in patients. The investigators aim to develop a stimulation protocol suited to induce a clinically relevant improvement of prefrontal functions in patients suffering from alcohol dependency. Therefore, the investigators will develop stimulation protocols which are able to modulate prefrontal activation for a much longer time course than those currently available, and will explore if the induced physiological alterations translate to respective cognitive improvements and reduction of addictive behaviour.
A hallmark of alcoholism is the deficiency of the frontal lobe, characterized by deficits in attention and working memory and executive dysfunction. This condition is especially marked by an inability to abstain from alcohol, having direct implications for the treatment of alcoholism (Goldstein and Volkow 2002).
In a previous study, we examined the frontal function by the Frontal Assessment Battery (FAB) and mental state through the Mini-Mental State Examination (MMSE) in 170 patients with alcoholism classified according to Lesch's typology (Zago-Gomes and Nakamura- Palacios 2009). In a global analysis, the alcoholics showed total scores on MMSE and FAB significantly smaller compared to non-alcoholics subjects. Type IV alcoholics showed lower scores on MMSE and FAB in comparison with non-alcoholics and all other types (Lesch's types I, II and III) of alcoholics. In a more specific analysis, even in alcoholics Type IV who had mental function (MMSE) preserved, the executive function (FAB) was significantly reduced (Zago-Gomes and Nakamura-Palacios 2009).
Moselhy et al. (2001) suggest that the frontal cognitive deficits observed in alcoholic patients are important predictors of therapeutic results. According to Lesch et al (1989, 1990, and in personal communication), Type IV alcoholics, who showed more severe frontal deficits are the ones who have the worst prognosis, with great difficulty in abstaining from alcohol, but still being treatable under intensive and multiple approaches. Therefore, investigations of new perspectives for the treatment of these alcoholics are especially needed.
A technique of neuromodulation that has been increasingly used and tested is the transcranial Direct Current Stimulation (tDCS). In this method, a weak direct current is induced in the cerebral cortex through two electrodes usually placed on the scalp (Nitsche et al 2008). Several studies have shown that this noninvasive method of brain stimulation is associated with significant changes in cortical excitability - increasing or decreasing it according to the polarity of stimulation (Nitsche and Paulus 2000, Nitsche and Paulus 2001; Zaghi et al 2009). Animal studies from the 50s and 60s showed that the effects of tDCS are associated with changes in the threshold of neuronal membrane at rest (Bindman et al 1964b; Purpura and McMurtry 1965). There is evidence that anodal transcranial stimulation improves cognitive function in man, and this effect seems to be due to a strengthening of glutamatergic synapses (Fregni et al 2005, Iyer et al 2005, Nitsche et al 2003).
In a recent study we examined the clinical and electrophysiological (indicated by the P3 component) effects of tDCS application over the left dorsolateral prefrontal cortex (DLPFC) in different types of alcoholics according to Lesch's typology (data submitted for publication). We enrolled 49 alcoholics aging between 18 and 75 years old during the subacute period of abstinence. These individuals were submitted to event-related potentials (ERP) under the presentation of sounds related or non-related to the use of alcohol before, during and after active tDCS (1mA, 35 cm2, for 10 minutes) or sham procedure at a randomized and counterbalanced order. We observed a significant improvement in the FAB performance after the active tDCS compared to sham in Type IV alcoholics. There was an increase in the amplitude of P3 mainly in frontal site (Fz). This change was also more pronounced in Type IV alcoholics. Thus, we found clinical and electrophysiological evidence of increased frontal activity induced by tDCS specific to the type IV alcoholics. Considering that the frontal dysfunction, may contribute to the loss of control over drinking behavior, these results suggest that a local increase in frontal activity induced by tDCS may have a beneficial clinical impact.
Therefore, in this project we intend to continue this study, aiming now to investigate the potential beneficial effects of tDCS applied repeatedly (once a week for 5 consecutive weeks) on the left DLPFC in the treatment of alcoholism in the course of protracted withdrawal. The frontal function will be examined by the application of FAB and other cognitive tests. A clinical follow-up will be carefully conducted.
General objective: The main objective of this study is to examine the potential beneficial effects of repetitive transcranial direct current electrical stimulation over the left dorsolateral prefrontal cortex in the treatment of alcoholism in the course of its protracted withdrawal.
Specific objectives: Of the specific objectives include the verification of the effects of repetitive transcranial electrical stimulation (5 applications) on: (1) the records of event-related potentials over 32 brain regions, (2) craving, (3) the performance of the frontal assessment battery, (4) the performance of two-back visual-spatial working memory task, (5) the performance of two-back auditory working memory task, (6) the performance of the inhibitory control behavior in a Go / No-Go task, (7) the performance of error detection, mental flexibility and inhibitory control in a counting Stroop test, (8) the quality of life.
This study recruited thirty three alcoholics with diagnosis confirmed by Diagnostic and Statistical Manual of Mental Disorders in its Fourth Edition (DSM-IV) who present themselves voluntarily for treatment of Alcohol Dependence Syndrome in the outpatient public service at University Hospital Cassiano Antonio de Moraes from Health Sciences Center from Federal University of Espirito Santo (PAA / HUCAM / CCS / UFES), which were clinically stable and not requiring hospitalization, with significant history of consumption of at least 35 weekly doses of alcohol on average last year, and an active intake of at least 35 weekly doses of alcohol in the last 90 days before starting the study, and yet, being in a minimum of seven days of abstinence until beginning of the study protocol. They signed a consent form and were distributed randomly in two groups (sham and tDCS groups). Registrations of visual-cued (neutral or alcohol-related images) event-related potential (ERPs)were done before and after repetitive bilateral (left cathodal/right anodal) transcranial Direct Current Stimulation (tDCS, 5 x 7 cm2, 2 mA, double application - 13 min duration with 20 min interval in between)over the dorsolateral prefrontal cortex or sham procedure. tDCS or sham tDCS were applied once a day for 5 consecutive days. Cognitive tests (frontal assessment battery - FAB, mini-mental status examination - MMSE, verbal n-back task, visuospatial n-back task, go/no-go task) were done at the beginning of the session 1 and session 6. They were weekly followed up for 4 additional weeks and monthly over the following 5 months. Treatment of acute withdrawal followed the routine in the outpatient service (diazepam, vitamins and general support). They were examined weekly at the outpatient service for 4 weeks after the end of the protocol.
|Study Type ICMJE||Interventional|
|Study Phase||Phase 2|
|Study Design ICMJE||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Primary Purpose: Treatment
|Intervention ICMJE||Device: transcranial Direct Current Stimulation
transcranial Direct Current Stimulation (tDCS, 5 x 7 cm2, 1 mA, during 10 min) will be applied over the left dorsolateral prefrontal cortex once a week for 5 consecutive weeks.
Other Name: non-invasive brain stimulation
|Study Arm (s)||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
|Recruitment Status ICMJE||Completed|
|Completion Date||July 2013|
|Primary Completion Date||July 2013 (final data collection date for primary outcome measure)|
|Eligibility Criteria ICMJE||
|Ages||18 Years to 65 Years|
|Accepts Healthy Volunteers||No|
|Contacts ICMJE||Contact information is only displayed when the study is recruiting subjects|
|Location Countries ICMJE||Brazil|
|NCT Number ICMJE||NCT01330394|
|Other Study ID Numbers ICMJE||FAPES45397090/09|
|Has Data Monitoring Committee||No|
|Responsible Party||Ester Miyuki Nakamura-Palacios, Federal University of Espirito Santo|
|Study Sponsor ICMJE||Federal University of Espirito Santo|
|Information Provided By||Federal University of Espirito Santo|
|Verification Date||September 2013|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP